- Home
- AXIL vs BRNS Comparison
AXIL vs BRNS Comparison
Compare AXIL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | BRNS |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 55.9M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AXIL | BRNS |
|---|---|---|
| Price | $7.09 | $0.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 10.8K | ★ 30.4K |
| Earning Date | 04-10-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $53.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.04 | $0.51 |
| 52 Week High | $10.25 | $2.91 |
Technical Indicators
Market Signals| Indicator | AXIL | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 37.24 |
| Support Level | $4.76 | $0.51 |
| Resistance Level | $7.35 | $0.76 |
| Average True Range (ATR) | 0.36 | 0.04 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 88.10 | 16.67 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.